The global drug company Pfizer says its experimental COVID-19 vaccine is more than 90 per cent effective
The global drug company Pfizer says its experimental COVID-19 vaccine is more than 90 per cent effective
10 November 2020
Along with its German partner BioNTech, it's the first manufacturer to release data from a large-scale clinical trial.
The companies say they've so far found no serious safety concerns.
Stock markets in the US have jumped four per cent on the news.
© 2024 Newstalk ZB, NZCity
